Samsung Biologics is a fully integrated CDMO focused on the development and manufacture of biologics. Established in 2011, Samsung Biologics offers a full range of solutions for the biopharmaceutical industry, including cell line process and analytical method development, analytical services, and bulk cGMP manufacturing of drug substance and drug product from clinical to commercial scale.
Visit Company Website
